PRADAXA
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is PRADAXA discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that PRADAXA 150MG has been permanently discontinued (last updated October 19, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is PRADAXA not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
TEVA-DABIGATRAN
TEVA CANADA LIMITED
APO-DABIGATRAN
APOTEX INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02358808
Strength
150MG
Dosage Form
CAPSULE
Route
ORAL
Active Ingredient
DABIGATRAN ETEXILATE
Tier
Unrated
Last Updated
2017-10-19
Reason for Shortage
Business reasons
Other Products from BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02242119
250MG · DIN 02273322
20MCG · DIN 02247686
DIN 02419106
DIN 02231675
0.4MG · DIN 02270102
40MG · DIN 02415682
20MG · DIN 02415666
30MG · DIN 02415674
DIN 02459760
DIN 02459752
DIN 02441888